Target intelligence / Profile preview

Pseudomonas aeruginosa outer membrane and surface components (PA surface components)

Target
PA surface components
Molecular classification
Bacterial surface antigen, Outer membrane protein, Polysaccharide, Lectin, Porin
01

Overview

Pseudomonas aeruginosa outer membrane and surface components comprise a heterogeneous group of molecules including outer membrane proteins (Omps), lipopolysaccharides, and exopolysaccharides like Psl and Pel. These structures are essential for the bacterium's environmental adaptation, mediating adhesion to host cells and the formation of highly resistant biofilms (Moradali et al., 2017, Science Signaling). In the context of human disease, these components act as potent virulence factors that facilitate colonization of the respiratory tract, particularly in patients with cystic fibrosis or those requiring mechanical ventilation (Guvener & Harwood, 2007, Molecular Microbiology). Because these molecules are surface-exposed, they are primary targets for the host immune system and for the development of novel therapeutics such as monoclonal antibodies and vaccines. For instance, the bispecific antibody MEDI3902 targets both the Psl exopolysaccharide and the PcrV protein to inhibit attachment and neutralize the Type III secretion system (DiGiandomenico et al., 2014, Science Translational Medicine). Despite their promise, the significant phenotypic diversity and ability of P. aeruginosa to modulate surface expression present substantial challenges for achieving broad-spectrum efficacy across different clinical isolates.

Other names
Pseudomonas aeruginosa surface antigensP. aeruginosa outer membrane proteinsPA surface polysaccharidesPseudomonas cell surface components
02

Mechanism of action

Opsonophagocytic killing, inhibition of bacterial adhesion, neutralization of virulence factors, and disruption of biofilm formation.

03

Biological functions

Cell wall integrityAdhesionBiofilm formationVirulenceNutrient transportImmune evasion
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsisUrinary tract infection
05

Safety considerations

Antigenic variation leading to immune escapePotential for inflammatory response during bacterial lysisStrain-specific efficacyLow immunogenicity of certain polysaccharides
06

Interacting drugs

MEDI3902

4 more in the full profile.

07

Biomarkers

P. aeruginosa culture positivityAnti-Psl antibody titersAnti-PcrV antibody titersSputum bacterial load

Beyond the preview

Go deeper on Pseudomonas aeruginosa outer membrane and surface components (PA surface components).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa outer membrane and surface components (PA surface components).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call